The US Oncology Genetic Risk Evaluation and Testing (GREAT) program is pleased to present a two-day intermediate to advanced course for providers seeking to maintain depth and breadth of knowledge to integrate genetics and genomics into clinical oncology practice.

• Recent advances in genetics, genomics, and precision medicine

• The expanding role and overlap of somatic and germline genetics in cancer care

• Practical and relevant clinical updates

• Risk management for Hereditary Breast/Ovarian Cancer and Lynch

• Ethical, legal, and social Issues

• Unusual and challenging cases

• Service delivery models

The conference will be submitted for CME accreditation and also Category 1 through NSGC. We anticipate accreditation up to 13 credit hours.